Drug profile · INN
liothyronine sodium
TRIOSTAT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
liothyronine sodium (TRIOSTAT) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN liothyronine sodium
Brand TRIOSTAT
Route INJECTION
Formulation INJECTABLE
Originator Teva Pharma GmbH
Frequently asked questions
What is liothyronine sodium?
liothyronine sodium (TRIOSTAT) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for liothyronine sodium?
TRIOSTAT is a marketed brand name for liothyronine sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of liothyronine sodium?
liothyronine sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.